Seoul, South Korea

Uh Taek Oh




Average Co-Inventor Count = 13.8

ph-index = 2

Forward Citations = 30(Granted Patents)


Location History:

  • Kyunggi-do, KR (2006 - 2011)
  • Seoul, KR (2010 - 2011)

Company Filing History:


Years Active: 2006-2011

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Inventor Uh Taek Oh

Introduction

Uh Taek Oh is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for pain management. With a total of 5 patents, his work focuses on addressing various medical conditions through innovative solutions.

Latest Patents

Among his latest patents, Uh Taek Oh has developed thiourea derivatives and pharmaceutical compositions that act as modulators for the vanilloid receptor (VR). These inventions aim to provide effective treatments for a range of diseases associated with the activity of the vanilloid receptor, including acute pain, chronic pain, neuropathic pain, and various inflammatory conditions. His research highlights the potential of these compounds in treating ailments such as migraine, arthralgia, and respiratory disorders.

Career Highlights

Throughout his career, Uh Taek Oh has worked with prominent companies in the pharmaceutical industry, including Amorepacific Corporation and Pacific Corporation. His expertise in drug development and innovative research has positioned him as a key figure in the advancement of therapeutic solutions.

Collaborations

Uh Taek Oh has collaborated with talented individuals in his field, including Jin Kwan Kim and Yeon Su Jeong. These partnerships have contributed to the success of his research and the development of his patented inventions.

Conclusion

In summary, Uh Taek Oh is a distinguished inventor whose work in pharmaceuticals has led to significant advancements in pain management and treatment options. His innovative approach continues to impact the medical field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…